ANDA 209766, held by Ph Health. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 209766 (Diltiazem Hydrochloride), held by Ph Health, was first approved by FDA on May 30, 2018, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 30, 2018 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Diltiazem Hydrochloride360MG ยท capsule, extended release;oral | Diltiazem Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters